Is Outset Medical Stock a Good Investment?
Outset Medical Investment Advice | OM |
- Examine Outset Medical's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Outset Medical's leadership team and their track record. Good management can help Outset Medical navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact Outset Medical's business and its evolving consumer preferences.
- Compare Outset Medical's performance and market position to its competitors. Analyze how Outset Medical is positioned in terms of product offerings, innovation, and market share.
- Check if Outset Medical pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Outset Medical's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Outset Medical stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Outset Medical is a good investment.
Sell | Buy |
Hold
Market Performance | Very Weak | Details | |
Volatility | Unstable | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Responds to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Outset Medical Stock
Researching Outset Medical's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 19.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 0.06. Outset Medical recorded a loss per share of 36.9. The entity had not issued any dividends in recent years. The firm had 1:15 split on the 20th of March 2025.
To determine if Outset Medical is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Outset Medical's research are outlined below:
| Outset Medical generated a negative expected return over the last 90 days | |
| Outset Medical has high historical volatility and very poor performance | |
| The company generated the yearly revenue of 113.69 M. Annual Net Loss to common stockholders was (127.98 M) with gross profit of 39.14 M. | |
| Outset Medical reports about 227.52 M in cash with (116.3 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.71. | |
| Latest headline from news.google.com: Outset Medical stock target cut to 15 at TD Cowen - Investing.com |
Outset Medical Quarterly Accounts Payable |
|
Outset Medical uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Outset Medical. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Outset Medical's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 12th of February 2024 Upcoming Quarterly Report | View | |
| 1st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 12th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Outset Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Outset Medical's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2021-11-03 | 2021-09-30 | -0.73 | -0.65 | 0.08 | 10 | ||
2021-03-09 | 2020-12-31 | -0.66 | -0.75 | -0.09 | 13 | ||
2022-02-16 | 2021-12-31 | -0.77 | -0.87 | -0.1 | 12 | ||
2021-05-05 | 2021-03-31 | -0.81 | -0.7 | 0.11 | 13 | ||
2023-08-02 | 2023-06-30 | -0.78 | -0.9 | -0.12 | 15 | ||
2023-05-03 | 2023-03-31 | -0.74 | -0.9 | -0.16 | 21 | ||
2022-08-01 | 2022-06-30 | -0.7 | -0.92 | -0.22 | 31 | ||
2025-02-20 | 2024-12-31 | -6.1875 | -5.55 | 0.6375 | 10 |
Outset Medical Target Price Consensus
Outset target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Outset Medical's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 5 | Strong Buy |
Most Outset analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Outset stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Outset Medical, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationOutset Medical Target Price Projection
Outset Medical's current and average target prices are 10.89 and 3.75, respectively. The current price of Outset Medical is the price at which Outset Medical is currently trading. On the other hand, Outset Medical's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Outset Medical Market Quote on 7th of April 2025
Target Price
Analyst Consensus On Outset Medical Target Price
Outset Medical Analyst Ratings
Outset Medical's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Outset Medical stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Outset Medical's financials, market performance, and future outlook by experienced professionals. Outset Medical's historical ratings below, therefore, can serve as a valuable tool for investors.Know Outset Medical's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Outset Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Outset Medical backward and forwards among themselves. Outset Medical's institutional investor refers to the entity that pools money to purchase Outset Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Two Sigma Investments Llc | 2024-12-31 | 488.6 K | Deutsche Bank Ag | 2024-12-31 | 417.5 K | Two Sigma Advisers, Llc | 2024-12-31 | 412.5 K | Birchview Capital, Lp | 2024-12-31 | 368.8 K | Assenagon Asset Management Sa | 2024-12-31 | 289.8 K | State Street Corp | 2024-12-31 | 190 K | Tudor Investment Corp Et Al | 2024-12-31 | 180.4 K | Squarepoint Ops Llc | 2024-12-31 | 156.8 K | Jane Street Group Llc | 2024-12-31 | 109.1 K | Fmr Inc | 2024-12-31 | 3.7 M | Vanguard Group Inc | 2024-12-31 | 2.6 M |
Outset Medical's market capitalization trends
The company currently falls under 'Small-Cap' category with a market capitalization of 192.75 M.Market Cap |
|
Outset Medical's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.46) | (0.49) | |
| Return On Capital Employed | (0.49) | (0.52) | |
| Return On Assets | (0.46) | (0.49) | |
| Return On Equity | (4.77) | (4.53) |
Determining Outset Medical's profitability involves analyzing its financial statements and using various financial metrics to determine if Outset Medical is a good buy. For example, gross profit margin measures Outset Medical's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Outset Medical's profitability and make more informed investment decisions.
Evaluate Outset Medical's management efficiency
Outset Medical has Return on Asset (ROA) of (0.2286) % which means that for every 100 dollars spent on asset, it generated a loss of $0.2286. This is way below average. Likewise, it shows a return on total equity (ROE) of (1.7097) %, which implies that it produced no returns to current stockholders. Outset Medical's management efficiency ratios could be used to measure how well Outset Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of the 7th of April 2025, Return On Tangible Assets is likely to drop to -0.49. In addition to that, Return On Capital Employed is likely to drop to -0.52. At this time, Outset Medical's Fixed Asset Turnover is very stable compared to the past year. As of the 7th of April 2025, Asset Turnover is likely to grow to 0.43, while Return On Tangible Assets are likely to drop (0.49).| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.52 | 0.64 | |
| Tangible Book Value Per Share | 0.52 | 0.64 | |
| Enterprise Value Over EBITDA | (7.62) | (8.00) | |
| Price Book Value Ratio | 32.25 | 33.87 | |
| Enterprise Value Multiple | (7.62) | (8.00) | |
| Price Fair Value | 32.25 | 33.87 | |
| Enterprise Value | 745.5 M | 708.2 M |
Outset Medical has shown resilience through effective management strategies. Our analysis examines how these strategies influence financial outcomes and investor returns which helps in understanding the stock's long-term potential.
Beta 1.905 |
Basic technical analysis of Outset Stock
As of the 7th of April, Outset Medical holds the Coefficient Of Variation of (1,911), variance of 64.78, and Risk Adjusted Performance of (0.05). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Outset Medical, as well as the relationship between them. Please check Outset Medical risk adjusted performance, variance, as well as the relationship between the Variance and potential upside to decide if Outset Medical is priced some-what accurately, providing market reflects its current price of 10.89 per share. Given that Outset Medical has information ratio of (0.03), we recommend you to check out Outset Medical's recent market performance to make sure the company can sustain itself at a future point.Outset Medical's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Outset Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Outset Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Outset Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Outset Medical's Outstanding Corporate Bonds
Outset Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Outset Medical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Outset bonds can be classified according to their maturity, which is the date when Outset Medical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Understand Outset Medical's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Outset Medical's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.05) | |||
| Market Risk Adjusted Performance | (0.29) | |||
| Mean Deviation | 5.48 | |||
| Coefficient Of Variation | (1,911) | |||
| Standard Deviation | 8.05 | |||
| Variance | 64.78 | |||
| Information Ratio | (0.03) | |||
| Jensen Alpha | (0.20) | |||
| Total Risk Alpha | 0.6712 | |||
| Treynor Ratio | (0.30) | |||
| Maximum Drawdown | 48.31 | |||
| Value At Risk | (12.08) | |||
| Potential Upside | 11.37 | |||
| Skewness | 1.65 | |||
| Kurtosis | 5.85 |
| Risk Adjusted Performance | (0.05) | |||
| Market Risk Adjusted Performance | (0.29) | |||
| Mean Deviation | 5.48 | |||
| Coefficient Of Variation | (1,911) | |||
| Standard Deviation | 8.05 | |||
| Variance | 64.78 | |||
| Information Ratio | (0.03) | |||
| Jensen Alpha | (0.20) | |||
| Total Risk Alpha | 0.6712 | |||
| Treynor Ratio | (0.30) | |||
| Maximum Drawdown | 48.31 | |||
| Value At Risk | (12.08) | |||
| Potential Upside | 11.37 | |||
| Skewness | 1.65 | |||
| Kurtosis | 5.85 |
Consider Outset Medical's intraday indicators
Outset Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Outset Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Outset Medical Corporate Filings
8K | 20th of March 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 17th of March 2025 Other Reports | ViewVerify | |
F4 | 11th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
10K | 28th of February 2025 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
Outset Stock media impact
Far too much social signal, news, headlines, and media speculation about Outset Medical that are available to investors today. That information is available publicly through Outset media outlets and privately through word of mouth or via Outset internal channels. However, regardless of the origin, that massive amount of Outset data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Outset Medical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Outset Medical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Outset Medical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Outset Medical alpha.
Outset Medical Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Outset Medical can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Outset Medical Historical Investor Sentiment
Investor biases related to Outset Medical's public news can be used to forecast risks associated with an investment in Outset. The trend in average sentiment can be used to explain how an investor holding Outset can time the market purely based on public headlines and social activities around Outset Medical. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Outset Medical's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Outset Medical and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Outset Medical news discussions. The higher the estimate score, the more favorable the investor's outlook on Outset Medical.
Outset Medical Corporate Management
| Laura Romike | Senior Sales | Profile | |
| Jennifer Sipple | Senior Experience | Profile | |
| Stacey Porter | Chief Officer | Profile | |
| Mark MS | Chief Officer | Profile | |
| Steven Williamson | Chief Officer | Profile | |
| Marc Nash | Senior RD | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Outset Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. To learn how to invest in Outset Stock, please use our How to Invest in Outset Medical guide.You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Outset Medical. If investors know Outset will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Outset Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (36.90) | Revenue Per Share | Quarterly Revenue Growth (0.03) | Return On Assets | Return On Equity |
The market value of Outset Medical is measured differently than its book value, which is the value of Outset that is recorded on the company's balance sheet. Investors also form their own opinion of Outset Medical's value that differs from its market value or its book value, called intrinsic value, which is Outset Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Outset Medical's market value can be influenced by many factors that don't directly affect Outset Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Outset Medical's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Outset Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Outset Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.